The Drugs Controller General of India DCGI had on Friday permitted Bharat Biotech to conduct phase 3 clinical trials of its indigenously developed Covid-19 vaccine with certain conditions.from Top India News- News18.com https://ift.tt/3koPi4g
The Drugs Controller General of India DCGI had on Friday permitted Bharat Biotech to conduct phase 3 clinical trials of its indigenously developed Covid-19 vaccine with certain conditions.